Moreover, lipocalin 2 (LCN2), is commonly used as a biomarker of drug-induced kidney injury14 and is associated with renal disease progression.15 Overall, this data further reinforces the relationship between inflammation and the gene expression profile of PTECs grown in static non-coated conditions. This evidence concerns the gene LCN2 and kidney disorder.